Inspire Medical Systems Inc
INSP
ISIN null / Valor 41329373
Inspire Medical Systems Inc
UMushroom community rating:
About company
Inspire Medical Systems Inc. was established in 2007 after the Inspire technology and intellectual property portfolio were spun out of Medtronic. Since its inception, the company has prioritized successful patient outcomes and care experiences, with a motto of putting the patient first to guide its operations. Inspire has made significant investments in the Inspire patient experience reporting (PER) system to continuously improve the patient experience.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (03.04.2026):
Inspire Medical Systems Inc — fourth quarter of 2025 (and full year 2025): The company reported preliminary, unaudited revenue for Q4 2025 of $268.9M–$269.1M (≈12% YoY growth) and preliminary full-year 2025 revenue of $911.8M–$912.0M (≈14% YoY). Inspire also provided initial full-year 2026 revenue guidance and announced a new CFO appointment.
Preliminary Q4 2025 revenue
Inspire expects fourth-quarter 2025 revenue of $268.9M to $269.1M, about a 12% increase versus Q4 2024. These figures are preliminary and unaudited.
Preliminary full-year 2025 revenue
Full-year 2025 revenue is anticipated to be $911.8M to $912.0M, roughly a 14% increase over 2024, per the company’s preliminary results.
2026 revenue guidance
Initial full-year 2026 guidance is $1,003M to $1,013M, implying 10%–11% growth versus the company’s preliminary 2025 revenue range. Management reaffirmed the outlook given on its Q3 call.
Preliminary / audit caveat
The results are preliminary and unaudited; consolidated financial statements and the annual audit for the year ended December 31, 2025 are not complete and could lead to material changes to these figures.
Drivers and reimbursement note
Management cited strong momentum from the launch and growing acceptance of the Inspire V system as a driver of late-2025 growth. The 2026 outlook does not assume any contribution from potential increased reimbursement; the company is working with agencies on coding clarification and will update as appropriate.
CFO appointment
Inspire appointed Matt Osberg as Executive Vice President and Chief Financial Officer, with a start date of January 19, 2026; the company thanked outgoing CFO Rick Buchholz.
Investor engagement
Inspire noted participation in the 44th Annual J.P. Morgan Healthcare Conference and a formal presentation on January 12, 2026. Investor contacts and forward-looking statement cautions were included in the release.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1621 M
Market cap (USD)
1,109,128
Daily traded volume (Shares)
187.48 / 182.03
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
